FDA Approved Prescribed Nasal Spray Treatments for TRD Patients
There are various methods of treating depression, however there are individuals that suffer from a condition called TRD (Treatment Resistant Depression). Esketamine treatment is a new, modern and revolutionary therapy that is effective within hours of application. The drug itself is FDA approved and derived from a common anesthetic to treat depression called ketamine.
As a more potent version of ketamine, lower doses with fewer side effects are possible! Give Vik Shukla M.D. a call today to schedule your initial appointment at our local Gastonia, NC office.
Esketamine (Spravato)
ESKETAMINE/SPRAVATO: One of two non-invasive treatment for TRD (Treatment Resistant Depression) after failure of 2 or more adequate treatment with anti-depressants:
Twice a week spray inhalation in physician supervised care followed by 2 hours required monitoring in physician office. It is 4 weeks (total 8 treatments). Followed by 1 a week maintenance treatment as needed.
Dr. Vik Shukla is certified for Spravato treatment through rems program as well as TMS trained.
How Does It Treat Depression?
Patients who have received esketamine treatment have shown that they receive rapid relief, a decrease in suicidal thoughts, helps the brain develop new connections and is effective for Treatment Resistant Depression.